Science and Technology Grants

The City of Lafayette, through its Historic Preservation Board (HPB), offers competitive grants aimed at the direct support and preservation of older buildings within Lafayette city limits. These grants are designed to maintain and enhance the historic character of the community, aligning with the broader mission of preserving local heritage and extending the lifespan of significant structures. The program underscores a commitment to fostering a sense of place and historical continuity for current and future residents. Target beneficiaries for this grant program are owners of commercial buildings, houses, churches, outbuildings, and barns that are 50 years old or older and located within Lafayette city limits. The impact goals are to encourage the restoration, repair, and overall improvement of these historic structures. Expected outcomes include the physical preservation of architectural heritage, improved structural integrity of older buildings, and the continued use of historic materials or the use of identical/similar materials when original ones are not feasible. The program prioritizes projects that extend the life of the building, enhance its historic character, and, where possible, involve Lafayette-based businesses or DIY efforts. Projects that remove non-historic features to expose original ones are also encouraged. Urgency of need is a significant factor in assessment, alongside the longevity impact of the project and the appearance achieved through the use of historic materials. Research on the property's history is also encouraged, drawing on local historical resources. Eligible improvements include structural repairs (like foundation work), restoration of original windows and doors, roof repair/replacement, gutter installation, masonry cleaning and restoration, and the reconstruction of original architectural details. Painting is also eligible, with an emphasis on determining original colors. Measurable results include the number of buildings preserved, the extent of historic materials retained or accurately replicated, and the overall improvement in the condition and historic authenticity of funded projects. The underlying theory of change is that by providing financial incentives and clear guidelines, the City of Lafayette can empower property owners to take an active role in preserving the city's unique historical fabric, contributing to community pride and economic vitality.

This grant provides funding for early-phase clinical trials aimed at improving treatments for service-connected eye injuries and visual dysfunction in military personnel and veterans.

This program provides quick funding to researchers at North Carolina universities and nonprofit institutes to develop innovative life sciences projects that show strong commercial potential.

Project Title: Natural Resources Support - Black Abalone at Vandenberg SFB, California A cooperative agreement is being offered ONLY to members of the Cooperative Ecosystem Studies Units (CESU) Program Region(s) identified above. Award will be made upon mutual agreement and acceptance of the terms and conditions contained in the request for proposal and the of the recipient's CESU Master Agreement. Note the established CESU Program indirect rate is 17.5%. Responses to this Request for Statements of Interest will be used to identify potential organizations for this project. Approximately $50,000.00 is expected to be available to support this project for the base period. Additional funding may be available to the successful recipient for optional tasks and/or follow on work in subsequent years. NOTE: This project will be awarded under the authority of 16 USC 670c-1, Sikes Act: For projects for the implementation and enforcement of integrated natural resources management plans, priority shall be given to award to Federal and State agencies having responsibility for the conservation or management of fish or wildlife. Period of Performance: The base period of agreement will extend 18-months from date of award (3-month administrative period for project preparation, 12-months of technical support/field work, 3-month administrative period to complete deliverables). There may be up to five 18-month follow-on periods based on availability of funding. Description of Anticipated Work: See attached Statement of Objectives NOTE: At this time we are only requesting that you demonstrate available qualifications and capability for performing similar or same type of work by submitting a Statement of Interest. A full proposal and budget are NOT requested at this time. Submission of Your Statement of Interest1. Statements of Interest are due by 12:00 P.M., Central Time, on 17 June 2024.2. Submit your Statement of Interest via e-mail attachments or direct questions to:Sandy JustmanGrants SpecialistUSACE, Fort Worth DistrictEmail: nicholas.a.aprea@usace.army.milOffice: 817-886-1073David LeptienProject ManagerUSACE, Fort Worth DistrictEmail: david.b.leptien@usace.army.milOffice: 402-889-5570Review of Statements Received: All statements of interest received from a member of the CESU Region(s) identified above will be evaluated by a board comprised of one or more people at the receiving installation or activity, who will determine which statement(s) best meet the program objectives: offer the most highly qualified Principal Investigator, have the most relevant experience and the highest capability to successfully meet the program objectives. Submitters whose statements are determined to best meet the program objectives will be invited to submit a full proposal. Review Related Documents Tab for the full Project Details.

This grant provides funding for researchers to develop and test new treatments or technologies aimed at preventing and addressing eye injuries and visual dysfunction related to military service.

This grant provides funding for collaborative research teams to advance the understanding and treatment of eye injuries and visual dysfunction caused by military-related exposures.

This grant provides funding for innovative research projects aimed at improving the understanding and treatment of eye injuries and visual dysfunction related to military service.

The DoD Traumatic Brain Injury and Psychological Health, Translational Research Award aims to fund research that accelerates the application of findings in psychological health and traumatic brain injury into clinical practice, leading to the development of healthcare products, technologies, or clinical practice guidelines that improve patient outcomes.

The CATALYST Grant aims to enhance the capabilities, efficiency, and competitiveness of small and medium-sized manufacturers in South Carolina by promoting the adoption of Advanced Manufacturing Technologies (AMT), Quality Management Systems (QMSs), and Lean Manufacturing tools. Eligible manufacturers must have a NAICS code beginning with 31, 32, or 33, be physically located in South Carolina for at least one year, operate within the Department of Defense supply chain, and employ at least four workers. The grant supports consultative assessments to identify opportunities for AMT deployment and funds pilot projects in areas such as augmented reality training, digital work instructions, and robotics. The grant application opens on October 5, 2023, following an informational webinar, and closes on June 30, 2024, or when all slots are filled. The grant provides funding for projects recommended by AMT assessments, as well as QMS and Lean Manufacturing implementations to help manufacturers eliminate waste and reduce rework, improving their effectiveness as DIB suppliers.

The DoD Traumatic Brain Injury and Psychological Health, Focused Program Award is a funding opportunity aimed at accelerating the development of solutions to critical questions related to traumatic brain injury and psychological health, through multidisciplinary research programs that can significantly impact these conditions through clinical applications, with a budget of approximately $46.5M to fund around six projects.

Proposers must retrieve the instructions document (zip file) associated with the application package for this opportunity as there is at least one required form that must be attached to the submitted proposal package. The National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD) released its annual omnibus Research Announcement (NRA), Research Opportunities in Space and Earth Sciences (ROSES) 2024 (OMB Approval Number 2700-0092, CFDA Number 43.001) on February 14, 2024. In this case "omnibus" means that this NRA has many individual program elements, each with its own due dates and topics. All together these cover the wide range of basic and applied supporting research and technology in space and Earth sciences supported by SMD. Awards will be made as grants, cooperative agreements, contracts, and inter- or intra-agency transfers, depending on the nature of the work proposed, the proposing organization, and/or program requirements. However, most extramural research awards deriving from ROSES will be grants, and many program elements of ROSES specifically exclude contracts, because contracts would not be appropriate for the nature of the work solicited. The typical period of performance for an award is three years, but some programs may allow up to five years and others specify shorter periods. In most cases, organizations of every type, Government and private, for profit and not-for-profit, domestic and foreign (with some caveats), may submit proposals without restriction on teaming arrangements. Tables listing the program elements and due dates (Tables 2 and 3), a table that provides a very top level summary of proposal contents (Table 1), and the full text of the ROSES-2024 "Summary of Solicitation", may all be found NSPIRES at http://solicitation.nasaprs.com/ROSES2024. This synopsis is associated with one of the individual program elements within ROSES, but this is a generic summary that is posted for all ROSES elements. For specific information on this particular program element download and read the PDF of the text of this program element by going to Tables 2 or 3 of this NRA at http://solicitation.nasaprs.com/ROSES2024table2 and http://solicitation.nasaprs.com/ROSES2024table3, respectively, click the title of the program element of interest, a hypertext link will take you to a page for that particular program element. On that page, on the right side under "Announcement Documents" the link on the bottom will be to the PDF of the text of the call for proposals. For example, if one were interested in The Lunar Data Analysis Program (NNH24ZDA001N-LDAP) one would follow the link to the NSPIRES page for that program element and then to read the text of the call one would click on C.8 Lunar Data Analysis Program (.pdf) to download the text of the call. If one wanted to set it into the context of the goals, objectives and know the default rules for all elements within Appendix C, the planetary science division, one might download and read C.1 Planetary Science Research Program Overview (.pdf) from that same page. While the letters and numbers are different for each element within ROSES (A.12, B.7, etc.) the basic configuration is always the same, e.g., the letter indicates the Science Division (A is Earth Science, B is Heliophysics etc.) and whatever the letter, #1 is always the division overview. Frequently asked questions for ROSES are posted at http://science.nasa.gov/researchers/sara/faqs. Questions concerning general ROSES-2024 policies and procedures may be directed to Max Bernstein, Lead for Research, Science Mission Directorate, at sara@nasa.gov, but technical questions concerning specific program elements should be directed to the point(s) of contact for that particular element, who may be found either at the end of the individual program element in the summary table of key information or on the web list of topics and points of contact at: http://science.nasa.gov/researchers/sara/program-officers-list. Not all program elements are known at the time of the release of ROSES. To be informed of new program elements or amendments to this NRA, proposers may subscribe to: (1) The SMD mailing lists (by logging in at http://nspires.nasaprs.com and checking the appropriate boxes under "Account Management" and "Email Subscriptions"), (2) The ROSES-2024 blog feed for amendments, clarifications, and corrections to at https://science.nasa.gov/researchers/solicitations/roses-2024/, and (3) The ROSES-2024 due date Google calendars (one for each science division). Instructions are at https://science.nasa.gov/researchers/sara/library-and-useful-links (link from the words due date calendar).

The Pennsylvania Department of Agriculture is inviting applications for agricultural research grants for projects to be conducted from July 1, 2024, to June 30, 2026. The projects should address various critical areas such as pest infestation impacts, Chesapeake Bay farm management practices, pollinator protection, food action plans, urban agriculture, energy in agriculture, animal health, and robotic technology in farming. Funding is contingent upon the 2024-2025 budget appropriations, and the deadline for application submission is June 7, 2024. The department will evaluate the proposals based on a 100-point scale considering project needs, research outcomes, methodology, evaluation and replicability, industry support, and research team diversity.

The DOD Traumatic Brain Injury and Psychological Health, Emerging Topics Research Award aims to accelerate research in traumatic brain injury and psychological health, with the goal of developing new clinical applications, health care products, and guidelines for Service Members, their Families, Veterans, and the American public.

This program provides quick funding to researchers at North Carolina universities and nonprofit institutes to develop innovative life sciences projects that show strong commercial potential.

The DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award is a funding opportunity aimed at supporting the implementation of clinical trials that can significantly impact psychological health conditions and/or traumatic brain injury through the development of healthcare products, technologies, or practice guidelines.

The Flash Grant program, managed by the North Carolina Biotechnology Center (NCBiotech), aims to energize innovative ideas in the life sciences field that show early signs of exceptional commercial potential. Flash grants provide a quick infusion of funding at critical early stages to help shape innovative research ideas into high-potential life sciences technologies. The grants support short, focused research projects that generate initial exploratory, proof-of-concept, or feasibility data, or that conduct final experiments to advance research into the translational phase. These micro-grants target projects too early for traditional grant funding mechanisms and are available to researchers at any North Carolina university or nonprofit research institute.

This is a Request for Information (RFI) only. This RFI is not accepting applications for financial assistance. The purpose of this RFI is solely to solicit input for ARPA-E consideration to inform the possible formulation of future programs. The purpose of this Request for Information (RFI) is to solicit input for a potential ARPA-E program focused on the development of highly insulating R-10-rated glass for windows and R-50-rated walls for residential and commercial building retrofit and new construction.1 This RFI aims to identify potential participants and gather insights to inform the development of a potential funding opportunity focused on these transformative technologies. Heating and cooling of residential and commercial buildings in the United States accounted for about 12% of total national energy consumption (amounting to 12 quadrillion British thermal units) in 2022.2 Approximately 45% of this heating, ventilation, and air conditioning (HVAC) energy was used to compensate for heat transfer through the building envelope (e.g., windows, walls, doors, attic, and air leaks).2 Reducing the energy a building uses has multiple benefits beyond lower utility costs and carbon dioxide emissions. Smaller, less expensive HVAC equipment and ducting systems would increase useful interior space and reduce demands on the electrical grid. To view the RFI in its entirety, please visit https://arpa-e-foa.energy.gov.

Maturing research ideas into clinical practice and patient benefit is at the heart of all CDMRP research programs. Despite significant investment, the gap between what is possible and what is achieved remains. Even after information, tools, and interventions have been successfully evaluated in their intended populations, the development of knowledge to support their broader dissemination and implementation has often remained outside the scope. The FY24 TBIPHRP HSRA intends to bridge the gap between research, practice, and policy by building real-world evidence on how interventions, clinical practices/guidelines, and policies can be deployed to targeted populations at the appropriate time.Research Scope: The FY24 HSRA will fund clinical research (including clinical trials). Preclinical and animal research are prohibited. Prospective or retrospective clinical research or clinical trials involving human subjects, human subject data/records, and human anatomical substances are allowed. Proposed clinical trials should include interventions, clinical practices/guidelines, and policies that are well-supported within the literature and in relevant patient population(s). This award may not be used to support studies requiring an exception from informed consent (EFIC).Key aspects of the FY24 TBIPHRP HSRA: Precision Medicine Approaches: When appropriate, the TBIPHRP encourages the use of precision medicine approaches. These tailored treatments deliver the right treatment at the right time while considering an individuals unique characteristics. Community-Based Participatory Research: The application must include Community-Based Participatory Research (CBPR) approaches in the development and execution of the clinical research/trial. CBPR approaches should be documented in Attachment 8. Preliminary data are required: Inclusion of preliminary data relevant to the proposed clinical research/trial is required. Untested novel interventions are discouraged: Novel interventions that have not been evaluated in the intended population(s) are discouraged. Applicants seeking funding for novel interventions should consider one of the other FY24 TBIPHRP announcements. Study Population: The application should demonstrate the availability of and access to a suitable patient population that will support a meaningful outcome for the study. The application should include a discussion of how accrual goals will be achieved, as well as the strategy for inclusion of women and minorities in the clinical trial appropriate to the objectives of the study. Studies utilizing human biospecimens or datasets that cannot be linked to a specific individual, gender, ethnicity, or race (typically classified as exempt from Inquiry Review Board [IRB] review) are exempt from this requirement. Clinical Trial Start Date: If applicable, the proposed clinical trial is expected to begin no later than 6 months after the award date. Intervention Availability: If applicable, the application should demonstrate the documented availability of and access to the drug/compound, device, and/or other materials needed, as appropriate, for the proposed duration of the study.The FY24 HSRA applications may include (not all inclusive): Research that accelerates the uptake and implementation of evidence-based research into clinical practice. Comparative effectiveness research comparing the benefits and harms of emerging or established interventions and strategies to prevent, diagnose, treat, and monitor health conditions in real-world settings. Development and evaluation of strategies to overcome barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. Analysis of existing data or resources to inform clinical practice. Modification of established clinical tools for their intended population or environment. Analysis of existing clinical tools to maximize patient-relevant outcomes. Identification and analysis of the circumstances that create a need to stop or reduce (de-implement) the use of interventions, tools, policies, and guidelines that are ineffective, unproven, low-value, or harmful are within scope. Analysis of TBI and/or psychological health outcomes associated with the implementation of clinical practice guidelines, evidence-based practices, and process improvements.Early-Career Investigator Partnering Option: The FY24 TBIPHRP HSRA includes an Early-Career Investigator Partnering Option that is structured to accommodate two Principal Investigators (PIs), one of whom is an Early-Career Investigator. The combined direct costs budgeted for the entire period of performance in the applications of the Initiating PI and Partnering PI should not exceed $2.5M. The PIs may have experience in similar or disparate scientific disciplines, but each PI is expected to bring distinct contributions to the application. One PI will be identified as the Initiating PI and will be responsible for most of the administrative tasks associated with application submission. The other investigator will be the Partnering PI. At least one of the Initiating or Partnering PIs must be an Early-Career Investigator. The intent is not to create mentor-mentee arrangement. Both PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. The application is expected to describe how the PIs unique experience/expertise combined as a partnership will better address the research question, how the unique experience/expertise that each individual brings to the application is critical for the research strategy and completion of the SOW, and why the work should be done together rather than through separate efforts. If recommended for funding, each PI will be named to an individual award within the recipient organization(s). For individual FY24 TBIPHRP HSRA submission requirements for the Initiating and Partnering PI, refer to S Section II.D.2, Content and Form of the Application Submission.A clinical trial is defined in 45 CFR 46.102 as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials. For more information, a Human Subject Resource Document is provided at https://cdmrp.health.mil/pubs/pdf/Human%20Subjects%20Resource%20Document.pdf.Clinical trials may be designed to evaluate pharmacologic agents (drugs or biologics), diagnostics, devices, therapies, clinical guidance, behavioral interventions, emerging approaches and technologies, and/or new indications for products currently U.S. Food and Drug Administration (FDA)-approved or -cleared. Interventions that are not FDA-regulated (or international equivalent) are within scope but the regulatory status must be documented in Attachment 12, Regulatory Strategy.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.Multi-Institutional Clinical Research/Trials: As of January 20, 2020, U.S. institutions engaged in non-exempt cooperative research must rely on a single IRB to review and approve the portion of the research conducted at domestic sites (45 CFR 46.114(b)). If the proposed, non-exempt research involves more than one U.S.-based institution, a written plan for single IRB review arrangements must be provided at the time of application submission or award negotiation. The lead institution responsible for developing the master protocol and master consent form should be identified and should be the single point of contact for regulatory submissions and requirements.Communication and data transfer between or among the collaborating institutions, as well as how specimens and/or imaging products obtained during the study will be handled, should be included in the appropriate sections of the application. A separate intellectual and material property plan agreed on by all participating institutions is also required for multi-institutional clinical research/trials.Relevance to Military Health: Relevance to the health care needs of Service Members, their Families, and Veterans is a key feature of this award. Investigators are encouraged to consider the following characteristics as examples of how a project may demonstrate relevance to military health: Explanation of how the project addresses an aspect of psychological health conditions and/or TBI that has direct relevance to the health and/or readiness of Service Members, their Families, and Veterans. Description of how the knowledge, information, products, or technologies gained from the proposed research could be implemented in a dual-use capacity to benefit the civilian population and also address a military need. Use of military or Veteran populations, samples, or datasets in the proposed research, if appropriate.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $15.5M to fund approximately four HSRA applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

DEVCOM CBC requires a capable and qualified company to provide labor support, supervisory support, materials, tools, and equipment to develop state-of-the-art semi-autonomous standoff DUV Raman Systems. The first two (2) systems should be capable of operating at 262 nm. The additional two (2) systems should be capable of operating below 250nm. The U.S. Army currently has a challenge to detect large and small quantities of chemicals solids and liquids) at standoff distances greater than two (2) meters on ground and surfaces to enhance avoidance and situational awareness of a chemically hazard environment. The Army is gathering data to determine Industrys ability to address this capability gap and determine the effectiveness deployment upon successful technological development. Additional information and attachments can be found on SAM.gov: SAM.gov ; SAM.gov Notice ID: W911SR-24-S-DUVS ; SAM.gov Title: Request for Information (RFI): Deep Ultraviolet (DUV) Raman Systems.

This funding opportunity supports international collaborations to improve the detection and response to biological threats, particularly in developing countries, by enhancing biosurveillance and biosecurity capabilities.